Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions
Authors
Keywords
STAT, Cancer & metastasis, Cell invasion, Cell migration, Angiogenesis, STAT3 inhibitors
Journal
CELLULAR SIGNALLING
Volume 92, Issue -, Pages 110275
Publisher
Elsevier BV
Online
2022-02-03
DOI
10.1016/j.cellsig.2022.110275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimigratory effect of pyrazole derivatives through the induction of STAT1 phosphorylation in A549 cancer cells
- (2021) Yaprak Dilber Şimay Demir et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of Mitochondrial ERK1/2 and STAT3
- (2021) Sabrina Bilotta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy
- (2020) Sruthi V. Hindupur et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R/STAT3 signaling axis
- (2020) Changliang Chen et al. ONCOGENE
- Direct inhibition of TLR4/MyD88 pathway by geniposide suppresses HIF1α‐independent VEGF expression and hepatocellular carcinoma angiogenesis
- (2020) Cheng Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Zn(S-pr-thiosal)2 complex attenuates murine breast cancer growth by inducing apoptosis and G1/S cell cycle arrest
- (2020) Sasa Benazic et al. Future Medicinal Chemistry
- TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth
- (2020) Qing Li et al. EXPERIMENTAL CELL RESEARCH
- Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC
- (2020) Hao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Redox Regulation of STAT1 and STAT3 Signaling
- (2020) Elena Butturini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation
- (2020) Sepideh Mirzaei et al. BIOMEDICINE & PHARMACOTHERAPY
- STAT3 and p53: Dual Target for Cancer Therapy
- (2020) Thu-Huyen Pham et al. Biomedicines
- Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
- (2019) Nagavalli Somasundaram et al. Journal of Hematology & Oncology
- The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
- (2019) So-Yeon Park et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells
- (2019) Gianluca Scarno et al. Frontiers in Immunology
- TYK2: An Upstream Kinase of STATs in Cancer
- (2019) Katharina Wöss et al. Cancers
- Molecular structure and function of Janus kinases: implications for the development of inhibitors
- (2019) Alba Garrido-Trigo et al. Journal of Crohns & Colitis
- STAT3 Activation and Oncogenesis in Lymphoma
- (2019) Fen Zhu et al. Cancers
- Signal Transducer and Activator of Transcription Protein 3 (STAT3): an Update on its Direct Inhibitors as Promising Anticancer Agents
- (2018) Arianna Gelain et al. CURRENT MEDICINAL CHEMISTRY
- STAT3: a multifaceted oncoprotein
- (2018) Aleks C. Guanizo et al. GROWTH FACTORS
- STAT3 and apoptosis challenges in cancer
- (2018) Nazanin Fathi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
- (2018) Jenny D. Beebe et al. PHARMACOLOGY & THERAPEUTICS
- Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
- (2018) Li Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
- (2018) Alessandro Prestipino et al. Science Translational Medicine
- STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
- (2018) Matthew J. Reilley et al. Journal for ImmunoTherapy of Cancer
- TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration
- (2017) Zhang Jianwei et al. PATHOLOGY & ONCOLOGY RESEARCH
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
- (2016) Dongsheng Xu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Roles of N-Myc and STAT interactor in cancer: From initiation to dissemination
- (2016) Hawley C. Pruitt et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis
- (2016) Pin Wu et al. Oncotarget
- Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies
- (2015) Yang Yu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- The Histological Classification of Diffuse Large B-cell Lymphomas
- (2015) Yi Xie et al. SEMINARS IN HEMATOLOGY
- HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer
- (2014) Kellie S. Rath et al. CANCER RESEARCH
- Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma
- (2014) Jonathan L. Berkowitz et al. CLINICAL IMMUNOLOGY
- STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
- (2014) Guo-Shi Lin et al. MEDICAL ONCOLOGY
- KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer
- (2014) YingYing Qian et al. Molecular Cancer
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer
- (2014) U Bharadwaj et al. ONCOGENE
- Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer
- (2013) Amir Sonnenblick et al. BREAST CANCER RESEARCH AND TREATMENT
- OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
- (2013) Mi-Jung Kim et al. CANCER LETTERS
- STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapyin vitroandin vivo
- (2013) Melanie Spitzner et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-Associated Macrophage Promotes Tumor Progression via STAT3 Signaling in Hepatocellular Carcinoma
- (2013) Yohei Mano et al. PATHOBIOLOGY
- Role of STAT3 in Cancer Metastasis and Translational Advances
- (2013) Mohammad Zahid Kamran et al. Biomed Research International
- Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer
- (2012) Sebastian F. Schoppmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Biology and significance of the JAK/STAT signalling pathways
- (2012) Hiu Kiu et al. GROWTH FACTORS
- Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer
- (2012) Hua Xiong et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma
- (2012) Makoto Adachi et al. ORAL ONCOLOGY
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
- (2011) R. B. Corcoran et al. CANCER RESEARCH
- STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers
- (2011) Teppei Morikawa et al. CLINICAL CANCER RESEARCH
- Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma
- (2011) Zheng-Sheng Wu et al. MELANOMA RESEARCH
- Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Better Prognosis, Cell Proliferation and Hypoxia-Inducible Factor-1α in Human Gastric Cancer
- (2011) Sungmin Woo et al. PATHOBIOLOGY
- Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis
- (2010) Keinosuke Ryu et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma
- (2009) S Takemoto et al. BRITISH JOURNAL OF CANCER
- Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
- (2009) Hao Min et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
- (2009) D. J. Gough et al. SCIENCE
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
- (2008) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- STAT3 expression in gastric cancer indicates a poor prognosis
- (2008) Dae-Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
- (2007) Rebecka Hellsten et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started